Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

67%

6 of 9 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

Phase 1

3(37.5%)

Phase 3

3(37.5%)

Phase 4

1(12.5%)

Phase 2

1(12.5%)

8Total

Phase 1(3)

Phase 3(3)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT01297465Phase 3Completed

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique

Role: collaborator

NCT01483560Phase 3Completed

REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)

Role: collaborator

NCT00982865Phase 1Completed

Trial of MSC1936369B in Subjects With Solid Tumors

Role: collaborator

NCT00938366Phase 1Completed

Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis Subjects

Role: collaborator

NCT01675999Phase 2Unknown

Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer

Role: collaborator

NCT01397136Completed

Cell-free DNA: a Non-invasive Test for Assessing Embryo Quality

Role: collaborator

NCT00911469Phase 1Completed

Study of AS902330 (rhFGF-18) Administered Intra-articularly in Patients With Knee Primary Osteoarthritis Who Are Candidates for Total Knee Replacement

Role: collaborator

NCT01419249Phase 4Completed

First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study

Role: collaborator

NCT01400698Phase 3Completed

Saizen in Intra-uterine Growth Retardation

Role: collaborator

NCT01108887Completed

An Observational Study for the Assessment of Adherence, Effectiveness and Convenience of Rebif® Treatment in Relapsing Multiple Sclerosis Patients Using RebiSmart™.

Role: collaborator

All 10 trials loaded